RPRXNasdaq United States
Market cap
$32.643 B
$56.77 -0.86%
Close of 7 Aug 2026
Revenue
$2.38B
#1049 by revenue
Earnings
$770.9M
#473 by earnings
Shares outstanding
—
Latest filing cover page
P/E ratio
42.3
Cap ÷ net income
Where these numbers come from
Share counts and financials for Royalty Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.